Cantor Fitzgerald began coverage on SoftBank shares, while TD Cowen reaffirmed its hold rating on the company.
1 report, 1 independent
Updated Jun 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald began coverage on SoftBank shares, while TD Cowen reaffirmed its hold rating on the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
SoftBank Group
Japanese company
-
Cantor Fitzgerald
American financial services company
-
TD Cowen
American investment bank
Related events
- Cantor Fitzgerald began coverage and issued rating, and Morgan Stanley upgraded price objective and rating for Silence Therapeutics.
- Cantor Fitzgerald raised its price target and rating for Supernus Pharmaceuticals, Inc. on September 2, 2026, and the company filed a disclosure with the SEC.
- Cantor Fitzgerald raised its price target and rating, while Bank of America adjusted its rating and price target, with MarketBeat aggregating the stock rating data.
- Cantor Fitzgerald and Wells Fargo raised price targets for Regeneron Pharmaceuticals stock.
- Cantor Fitzgerald initiated coverage with an overweight rating and price target for a company debuting on the New York Stock Exchange.